Huggins Lectureship The Immune System and Cancer A Civil War - PowerPoint PPT Presentation

1 / 33
About This Presentation
Title:

Huggins Lectureship The Immune System and Cancer A Civil War

Description:

In clinical trials, between 70-100% of patients responded with complete ... Activating inflammatory responses can lead to clearance of certain types of ... – PowerPoint PPT presentation

Number of Views:54
Avg rating:3.0/5.0
Slides: 34
Provided by: judyc82
Category:

less

Transcript and Presenter's Notes

Title: Huggins Lectureship The Immune System and Cancer A Civil War


1
Huggins LectureshipThe Immune System and
CancerA Civil War
  • Saturdays
  • January 12-March 1, 2008
  • Judy Cannon Ph.D.
  • Postdoctoral Fellow
  • Department of Medicine, Section of Pulmonary and
    Critical Care Medicine

2
Quiz-from Week 1 lecture
  • What are pathogens?
  • Microorganisms that cause disease
  • Viruses and fungi
  • All bacteria
  • What are two key players in the immune response?
  • Red blood cells
  • B and T cells
  • Islet cells
  • Cancer cells
  • (A) Grow without normal control
  • (B) Metastasize
  • (C) Mutate DNA
  • (D) All the above
  • Immunotherapy is
  • (A) Non specific cancer cell killing
  • (B) Chemotherapy
  • (C) Using the immune system to target and kill
    cancer cells

3
January 19th 2008Huggins Lecture
2Inflammation and the start of the adaptive
immune response
How does the immune system know when to go?
4
Site of infection
Lymph Node
Tumor site
3. T cell recognition Self vs. non-self
  • Danger
  • Inflammation

2. Presentation of viral products Antigen
presentation
7. Target cell killing
Tumor cell
Virally infected cell
4. Lymphocyte expansion
6. Target recognition
Non-specific cell
Specific T cell
5. Lymphocyte trafficking Getting back to the
right location
Dendritic cell
Specific B cell
5
Site of infection
Lymph Node
Tumor site
  • Danger
  • Inflammation

Tumor cell
Virally infected cell
Virally infected cell
Dendritic cell
6
What is inflammation?
  • Rubor redness-increased blood flow to site of
    infection
  • Calor heat-increased blood flow and cellular
    buildup.
  • Tumor swelling-increased cellular buildup at
    site of infection
  • Dolor pain-chemical mediators that signal pain
    to brain

7
Mediators of inflammationInnate ImmunityFirst
responders
www.lib.mcg.edu/edu/esimmuno/ch1/physresp.htm
8
Inflammation Maintaining balance
  • Biological systems Need to be in balance.
  • Too little leads to pathology.
  • Too much leads to pathology.

9
Inflammation
  • How is it good?
  • Leads to the start of the immune response
  • How is it bad?
  • Causes discomfort!
  • Cancer

10
What can cause too much inflammation?
  • Chronic infections
  • Hepatitis B and C-liver
  • Helicobacter pylori-stomach ulcers
  • Human Papilloma Virus-cervix
  • Genetic diseases
  • Inflammatory Bowel Disease

11
Chronic inflammation and cancer
  • Chronic infections
  • Hepatitis B and C
  • 20-30 times higher risk for liver cancer
  • Ulcers caused by bacteria
  • 3 times higher risk for stomach cancer
  • Human Papilloma Virus
  • Causes over 70 of all cases of cervical cancer
  • Genetic diseases
  • Inflammatory Bowel Disease
  • 2-3 times higher risk for colon cancer

12
How does inflammation cause cancer?
  • Not clear
  • Studies show that some of the mediators of
    inflammation might cause DNA damage.

Treatments?
  • Some evidence that anti-inflammatory drugs such
    as aspirin might decrease cancer rates.

13
When is inflammation good?
  • Kicks off immune response.
  • Signals from pathogens that tell the immune
    system that we are infected with a pathogen.

14
Coleys toxin
  • Dr. William Coley
  • Injected cancer patients with bacteria
  • Saw dramatic regression or complete cure in a few
    patients
  • Induce inflammation?

Courtesy Nature Publishing Group
15
Mediators of inflammationInnate ImmunityRapid
Response Team Macrophages and Neutrophils
www.lib.mcg.edu/edu/esimmuno/ch1/physresp.htm
16
Danger signals
www.biology.ualberta.ca/.../fly_lab/fly_lab.htm
17
Drosophila Melanogaster
  • One of the most intensively studied genetic
    organisms
  • Classical genetic studies throughout 20th century
  • Toll receptors identified in 1988.
  • Important for fruit fly immunity to fungus

18
Humans (and all mammals) have Toll-like
receptors, or TLRs
www.itb.cnr.it/
19
TLRs signal danger to the immune system for
bacteria and viruses
Bacterial and viral components
20
Site of infection
  • Danger
  • Inflammation

2. Presentation of pathogenic products Antigen
presentation
Virally infected cell
Dendritic cell
21
Dendritic cells
  • Reconaissance team
  • Gather information to take to the specialists-
  • army T cells
  • air force B cells
  • Dendritic cells start eating up nearby cells
  • Dendritic cells chew up cellular material and
    then display them to B and T cells
  • Dendritic cells move to lymph nodes

22
Dendritic cells-bridging the local and the lymph
node response
23
Figure 1-7
24
Site of infection
Tumor site
Lymph Node
1. Inflammation
2. Antigen presentation
Tumor cell
Virally infected cell
Dendritic cell
25
Infectious Agents vs. Cancer
  • External bacteria or virus
  • Internal cell from self

26
Site of infection
Tumor site
Lymph Node
1. Inflammation
2. Antigen presentation
Tumor cell
Virally infected cell
Dendritic cell
27
An intelligence failure What happens if there
is no inflammation?
  • No activation of local inflammatory response
  • No activation of dendritic cells and adaptive
    immune response
  • No antigen presentation-no T or B cell activation

28
Imiquimod or Aldara
  • FDA approved, on market now
  • Used to treat superficial basal cell carcinoma
  • Annual sales exceeded US 100 million
  • TLR agonist binds and activates Toll-Like
    receptor
  • Induces local inflammatory response

29
Imiquimod-brings first responders
www.lib.mcg.edu/edu/esimmuno/ch1/physresp.htm
30
Efficacy of Imiquimod
  • In clinical trials, between 70-100 of patients
    responded with complete clearance of basal cell
    carcinoma.
  • Side effect edema, burning sensation

31
Site of infection
Lymph Node
Tumor site
1. Inflammation
2. Antigen presentation
Tumor cell
Virally infected cell
Dendritic cell
32
Key points Lecture 2
  • Chronic inflammation can cause cancers.
  • Inflammation is a necessary first step to the
    immune response to bring first responders to
    control the infection
  • Inflammation leads to activation of antigen
    presentation and migration of dendritic cells to
    lymph nodes
  • Activating inflammatory responses can lead to
    clearance of certain types of tumors

33
Next week Lecture 3Immune cell recognition
January 26th 2008
  • How does the immune system see pathogens or
    cancer cells?
  • Immune cell recognition, autoimmunity, and cancer
    antigens.
Write a Comment
User Comments (0)
About PowerShow.com